Drawing for BIOCURE

USPTO serial 79271088

BIOCURE

Reviewed by CopyMark Law Group

Reg. 6010551Status 739Registered
Filing date
Status date
Registration date
Mar 17, 2020
Examiner
BILLINGS, JOHN T
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BIOCURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David S. Safran

David S. Safran Calderon Safran & Wright P.C.7918 Jones Branch Drive, Suite 500McLean, VA 22102United States

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical products for the foundry industry, in particular additives for the use in foundries for the production of moulds, cores and/or feeders; ] chemical additives for use as binding agents for the use in foundries for the production of moulds, cores and/or feeders; polyurethane-based artificial resin binders for the use in foundries for the production of moulds, cores [ andd] * and * /or feeders; chemical additives for use as binding agents comprising at least one phenolic resin component and/or at least one isocyanate component for binding moulds, cores and/or feeders in the foundry industry; unprocessed artificial resins, in particular artificial and synthetic resins as binding agents and additives for moulding sands in the foundry industry and/or for [ ore ] * core * sands in the foundry industryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 5, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 1, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 6, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 5, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 18, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 2, 2020INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Nov 23, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 22, 2020GPNXNOTIFICATION PROCESSED BY IB—
Apr 28, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 28, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 16, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Mar 23, 2020CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Mar 23, 2020COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Mar 23, 2020PLGLASSIGNED TO PARALEGAL—
Mar 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 15, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 7, 2020CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 31, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 11, 2019NPUBNOTICE OF PUBLICATION—
Nov 20, 2019ALIEASSIGNED TO LIE—
Nov 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2019DOCKASSIGNED TO EXAMINER—
Nov 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance